Infection Control

Global Infection Control Market to Reach US$83.4 Billion by 2030

The global market for Infection Control estimated at US$56.3 Billion in the year 2024, is expected to reach US$83.4 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Protective Barriers, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$34.8 Billion by the end of the analysis period. Growth in the Sterilization Products & Services segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$15.3 Billion While China is Forecast to Grow at 8.0% CAGR

The Infection Control market in the U.S. is estimated at US$15.3 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$12.9 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.4% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Infection Control Market - Key Trends & Drivers Summarized

What Defines the Scope and Importance of Infection Control Today?

Infection control is a critical discipline within healthcare that aims to prevent or stop the spread of infections in healthcare facilities and communities. This field encompasses various practices, processes, and procedures used to minimize the risk of infection. It involves the use of disinfection methods, sterilization procedures, and sanitation practices to protect patients and healthcare workers alike. Infection control is essential not only in hospitals but also in other settings such as clinics, nursing homes, and at home, especially when caring for the elderly or those with weakened immune systems. The significance of infection control has been underscored by recent global health crises, where the lack of proper practices led to widespread outbreaks, highlighting the need for stringent and effective infection control measures.

How Have Pandemics Reinforced the Necessity for Robust Infection Control Measures?

The COVID-19 pandemic has dramatically transformed the landscape of infection control, bringing unprecedented attention and resources to this field. Healthcare facilities worldwide have revised and updated their infection control protocols to handle the surge in patients while preventing the spread of the virus within and beyond their walls. This situation has accelerated innovation in infection control technologies, such as UV-C disinfection, HEPA filters, and advanced personal protective equipment (PPE). Moreover, it has led to increased governmental and institutional investments in training healthcare workers in the best practices for infection prevention and control, which is critical in managing not only the current pandemic but also future outbreaks.

Which Technological Innovations Are Revolutionizing Infection Control?

Technology plays a pivotal role in advancing infection control measures. The development of new diagnostic tools has enabled faster identification of pathogens, which is crucial for effective infection control. Advanced sterilization technology, such as low-temperature plasma sterilization, offers more efficient and safer alternatives to traditional methods, which often involved toxic chemicals or high heat. Robotics and automation have also been introduced in some healthcare settings to decontaminate rooms and equipment more thoroughly and consistently than manual cleaning. Furthermore, information technology has facilitated better tracking and data analysis to monitor infection rates and outcomes, significantly enhancing infection control programs` effectiveness.

What Are the Major Drivers of Growth in the Infection Control Market?

The growth in the infection control market is driven by several factors, including increased awareness of healthcare-associated infections (HAIs), technological advancements in sterilization and disinfection products, and global health crises such as the COVID-19 pandemic. There is a growing demand for effective infection control solutions across various healthcare settings, driven by the need to improve patient safety and meet stringent regulatory standards. Technological innovations have led to the development of more effective and efficient infection control products, which are being rapidly adopted by healthcare facilities worldwide. Additionally, shifts in consumer behavior, particularly the increased emphasis on sanitation and hygiene practices observed in both healthcare workers and the general public, are further propelling the market growth.

SCOPE OF STUDY:

The report analyzes the Infection Control market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Products & Services (Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products, Other Products & Services); End-Use (Hospitals & Clinics, Pharma & Medical Device Companies, Other End-Uses)

Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 145 Featured) -

• 3M Company
• AstraZeneca PLC
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• bioMerieux SA
• AliMed, Inc.
• Baumer SA
• Ansell Ltd.
• Allegion PLC
• Alfred Becht GmbH
• Belimed AG
• A-dec Inc.
• Advanced Sterilization Products
• Ahlstrom-Munksjo
• ABC Dentistry & Orthodontics

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.